Dymista approved by the FDA »
– [May 2, 2012]
Positive results for Dymista in three clinical studies »
– [March 5, 2012]
Meda announces PDUFA timeline for Dymista »
– [December 15, 2011]
Astepro patent granted
– [December 6, 2011]
Dymista Filed with FDA
– [April, 2011]
Positive Study Results Presented
– [March, 2011]
MEDA introduces EDLUARTM, the first and only sublingual tablet that contains the most prescribed sleep medication, zolpidem tartrate
– [September, 2009]
MEDA receives FDA approval of new ASTEPRO® (azelastine HCl) nasal spray 0.15%, the first and only once-daily nasal antihistamine
– [September, 2009]
FDA approval for Onsolis anticipated during summer 2009
– [June, 2009]
Positive study supporting a potential once-daily nasal antihistamine
– [May, 2009]
Edluar receives FDA approval
– [March, 2009]
Further inquiries should be directed to [email protected]